Henderson P S, Cohen J I, Jarnberg P O, Smith J D, Stevens W
Department of Otolaryngology-Head and Neck Surgery, Oregon Health Sciences University, Portland 97201.
Laryngoscope. 1992 Nov;102(11):1237-41. doi: 10.1288/00005537-199211000-00006.
Laryngospasm, if prolonged, can result in serious sequelae due to the lack of a uniformly effective treatment. Prevention, therefore, through pharmacologic intervention, is an attractive concept. In order to study the effects of various drugs in preventing laryngospasm, a reliable animal model capable of producing sequential, repetitive episodes of laryngospasm is necessary. In this study, the canine model of laryngospasm previously described by Aviv, et al. was modified to overcome technical factors which limited its use in this regard. Details of the technique and the results from eight animals will be presented. Results in two animals with the use of prophylactic topical lidocaine will also be discussed. The reliability and reproducibility of this model make it ideal for the study of laryngospasm and open the way for investigation into its prevention.
如果喉痉挛持续时间较长,由于缺乏统一有效的治疗方法,可能会导致严重的后遗症。因此,通过药物干预进行预防是一个有吸引力的概念。为了研究各种药物在预防喉痉挛方面的作用,需要一个可靠的动物模型,该模型能够产生连续、重复性的喉痉挛发作。在本研究中,对Aviv等人先前描述的犬类喉痉挛模型进行了改进,以克服限制其在这方面应用的技术因素。将介绍该技术的细节以及八只动物的实验结果。还将讨论两只使用预防性局部利多卡因的动物的实验结果。该模型的可靠性和可重复性使其成为研究喉痉挛的理想模型,并为研究其预防方法开辟了道路。